1. Home
  2. TNGX vs IBCP Comparison

TNGX vs IBCP Comparison

Compare TNGX & IBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • IBCP
  • Stock Information
  • Founded
  • TNGX 2014
  • IBCP 1864
  • Country
  • TNGX United States
  • IBCP United States
  • Employees
  • TNGX N/A
  • IBCP N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • IBCP Major Banks
  • Sector
  • TNGX Health Care
  • IBCP Finance
  • Exchange
  • TNGX Nasdaq
  • IBCP Nasdaq
  • Market Cap
  • TNGX 723.2M
  • IBCP 682.2M
  • IPO Year
  • TNGX N/A
  • IBCP N/A
  • Fundamental
  • Price
  • TNGX $8.76
  • IBCP $32.15
  • Analyst Decision
  • TNGX Strong Buy
  • IBCP Hold
  • Analyst Count
  • TNGX 6
  • IBCP 3
  • Target Price
  • TNGX $10.00
  • IBCP $36.00
  • AVG Volume (30 Days)
  • TNGX 2.1M
  • IBCP 109.7K
  • Earning Date
  • TNGX 11-06-2025
  • IBCP 10-28-2025
  • Dividend Yield
  • TNGX N/A
  • IBCP 3.23%
  • EPS Growth
  • TNGX N/A
  • IBCP N/A
  • EPS
  • TNGX N/A
  • IBCP 3.06
  • Revenue
  • TNGX $24,296,000.00
  • IBCP $217,457,000.00
  • Revenue This Year
  • TNGX $20.42
  • IBCP N/A
  • Revenue Next Year
  • TNGX N/A
  • IBCP $5.56
  • P/E Ratio
  • TNGX N/A
  • IBCP $10.51
  • Revenue Growth
  • TNGX N/A
  • IBCP 2.56
  • 52 Week Low
  • TNGX $1.03
  • IBCP $26.75
  • 52 Week High
  • TNGX $9.70
  • IBCP $40.32
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 58.17
  • IBCP 56.66
  • Support Level
  • TNGX $8.85
  • IBCP $30.55
  • Resistance Level
  • TNGX $9.31
  • IBCP $31.91
  • Average True Range (ATR)
  • TNGX 0.56
  • IBCP 0.71
  • MACD
  • TNGX 0.08
  • IBCP 0.16
  • Stochastic Oscillator
  • TNGX 67.60
  • IBCP 83.26

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About IBCP Independent Bank Corporation

Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.

Share on Social Networks: